Merck Partners to Speed Cancer Drug Trials
Merck and Sarah Cannon team up to help more people get into new cancer drug studies quickly.
Merck, a big drug company, now works with Sarah Cannon Research Institute. This team effort aims to find new ways to fight cancer. They want to make it easier for cancer patients to join important drug studies. These studies test new medicines.
Sarah Cannon helps people find these trials in their own communities. Many patients cannot travel far for treatment. This partnership brings the trials closer to home. It makes sure more people can take part.
The goal is to make cancer drug research faster and better. Finding new drugs quickly helps more patients. It gives them more hope. This work could change how we treat cancer in the future.
Source: FierceBiotech
More from Biotech
